Diffuse PRAME expression did not allow differentiation of MM from NMM (p = 0.81; Table 2) and was not a prognostic biomarker in melanomas ≤1.0 mm (Figure 2). The gene discussed is PRAME; the disease is Miyoshi myopathy.